Gabapentin can significantly improve dystonia severity and quality of life in children

European Journal of Paediatric Neurology

Volumn 20, Issue 1, 2016, Pages 100-107

  Liow, Natasha Yuan Kim ^a   Gimeno, Hortensia ^a,b   Lumsden, Daniel Edward ^a   Marianczak, Jennifer ^a   Kaminska, Margaret ^a   Tomlin, Stephen ^a   Lin, Jean Pierre Sao Ming ^a  

^a EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cerebral palsy; Children; Dystonia; Dystonia severity Assement Plan; Gabapentin; NBIA; WHO International Classification of function

Indexed keywords

BACLOFEN; GABAPENTIN; 4 AMINOBUTYRIC ACID; AMINE; AMINO ACID RECEPTOR BLOCKING AGENT; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE;

ANALGESIA; ARTICLE; CHILD; COHORT ANALYSIS; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG MEGADOSE; DYSTONIA; HUMAN; INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH; MAJOR CLINICAL STUDY; MOOD; MUSCLE SPASM; MUSCLE TONE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RETROSPECTIVE STUDY; SLEEP QUALITY; ADOLESCENT; DAILY LIFE ACTIVITY; DISABILITY; DYSTONIC DISORDERS; FEMALE; MALE;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; AMINES; CHILD; CYCLOHEXANECARBOXYLIC ACIDS; DISABILITY EVALUATION; DYSTONIA; DYSTONIC DISORDERS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; QUALITY OF LIFE; RETROSPECTIVE STUDIES;

EID: 84950326730     PISSN: 10903798     EISSN: 15322130     Source Type: Journal    
DOI: 10.1016/j.ejpn.2015.09.007     Document Type: Article

References (36)

1. D. Tarsy, and D.K. Simon Dystonia N Engl J Med 355 8 2006 08/24; 2014/02 818 829
2. H.L. Geyer, and S.B. Bressman The diagnosis of dystonia Lancet Neurol 5 9 2006 780 790
3. G. Defazio The epidemiology of primary dystonia: current evidence and perspectives Eur J Neurol 17 2010 9 14
4. A. Albanese, K. Bhatia, S.B. Bressman, and et al. Phenomenology and classification of dystonia: a consensus update Mov Disord 28 7 2013 863 873
5. X.O. Brakefield, A.J. Blood, Y. Li, and et al. The pathophysiological basis of dystonias. Nature reviews Neuroscience 9 3 2008 222 234
6. P. Greene, U.J. Kang, and S. Fahn Spread of symptoms in idiopathic torsion dystonia Mov Disord 10 2 1995 143 152
7. T.G. Nygaard, C.D. Marsden, and S. Fahn Dopa-responsive dystonia: long-term treatment response and prognosis Neurology 41 2 1991 174
8. H. Gimeno, A. Gordon, K. Tustin, and J. Lin Functional priorities in daily life for children and young people with dystonic movement disorders and their families Eur J Paediatr Neurol 17 2 2013 3 161 168
9. J.P. Lin, D.E. Lumsden, H. Gimeno, and M. Kaminska The impact and prognosis for dystonia in childhood including dystonic cerebral palsy: a clinical and demographic tertiary cohort study J Neurol Neurosurg Psychiatry 0 2014 1 6
10. S. Fahn High dosage anticholinergic therapy in dystonia Neurology 33 10 1983 October 01 1255 1261
11. A. Honarmand, M. Safavi, and M. Zare Gabapentin: an update on its pharmacological properties and therapeutic use in epilepsy J Res Med Sci 16 8 2011 1062 1069
12. A. Davies, J. Hendrich, A.T. Van Minh, and et al. Functional biology of the ±2′ subunits of voltage-gated calcium channels Trends Pharmacol Sci 28 5 2007 220 228
13. Ç. Eroglu, N.J. Allen, M.W. Susman, and et al. Gabapentin receptor α2δ-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis Cell 139 2 2009 10/16 380 392
14. M.A. Rose, and P.C.A. Kam Gabapentin: pharmacology and its use in pain management Anaesthesia 57 5 2002 451 462
15. D. Garcia-Borreguero, O. Larrosa, Y. de la Llave, and et al. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study Neurology 59 10 2002 November 26 1573 1579
16. J.P. Zacny, J.A. Paice, and D.W. Coalson Subjective, psychomotor, and physiological effects of pregabalin alone and in combination with oxycodone in healthy volunteers Pharmacol Biochem Behav 100 3 2012 1 560 565
17. R.P. Allen, C. Chen, D. Garcia-Borreguero, and et al. Comparison of pregabalin with pramipexole for restless legs syndrome N Engl J Med 370 2014 621 631
18. N.M. Allen, J.P. Lin, T. Lynch, and M.D. King Status dystonicus: a practice guide Dev Med Child Neurol 56 2 2014 105 112
19. World Health Organisation International Classification of Functioning Disability and Health: Children & Youth Version 2007 ISBN-10: 9241547324 and ISBN-13: 978-9241547321
20. R. Palisano, P. Rosenbaum, S. Walter, and et al. Development and reliability of a system to classify gross motor function in children with cerebral palsy Dev Med Child Neurol 39 4 1997 214 223
21. D.E. Lumsden, C. Lundy, C. Fairhurst, and J.P. Lin Dystonia severity action plan: a simple grading system for medical severity of status dystonicus and life-threatening dystonia Dev Med Child Neurol 55 7 2013 671 672
22. J.P. Rodrigues, D.J. Edwards, S.E. Walters, and et al. Gabapentin can improve postural stability and quality of life in primary orthostatic tremor Mov Disord 20 7 2005 865 870
23. V. Paliwal, P. Gupta, and S. Pradhan Gabapentin as a rescue drug in D-penicillamine-induced status dystonicus in patients with Wilson disease Neurol India 58 5 2010 9/1 761 763
24. R.S. Chudnow, R.A. Mimbela, D.B. Owen, and E.S. Roach Gabapentin for familial paroxysmal dystonic choreoathetosis Neurology 49 5 1997 1441 1442
25. J. Jankovic Hyperkinetic movement disorders in children 2013 Available at: http://www.uptodate.com/contents/hyperkinetic-movement-disorders-in-children?source=preview&anchor=H1&selectedTitle=3∼150#H1 [accessed 23.02.14]
26. D.E. Lumsden, M. Kaminska, H. Gimeno, K. Tustin, and et al. Proportion of life lived with dystonia inversely correlates with response to pallidal deep brain stimulation in both primary and secondary childhood dystonia Dev Med Child Neurol 55 6 2013 567 574
27. W.A. Marks, J. Honeycutt, F. Acosta, and et al. Dystonia due to cerebral palsy responds to deep brain stimulation of the globus pallidus internus Mov Disord 26 2011 1748 1751
28. A. Koy, M. Hellmich, K.A.M. Pauls, W. Marks, and et al. Effects of deep brain stimulation in dyskinetic cerebral palsy: a meta-analysis Mov Disord 28 5 2013 647 654
29. H. Gimeno, K. Tustin, D. Lumsden, and et al. Evaluation of functional goal outcomes using the Canadian occupational performance measure (COPM) following Deep brain stimulation (DBS) in childhood dystonia Eur J Paediatr Neurol 18 3 2014 308 316
30. H. Gimeno, K. Tustin, R. Selway, and J.P. Lin Beyond the Burke-Fahn-Marsden dystonia rating scale: deep brain stimulation in childhood secondary dystonia Eur J Paediatr Neurol 16 5 2012 501 508
31. B.D. Berman, P.A. Starr, W.J. Marks Jr., and J.L. Ostrem Induction of bradykinesia with pallidal deep brain stimulation in patients with cranial-cervical dystonia Stereotact Funct Neurosurg 87 1 2009 37 44
32. W.J. Hwang, D.B. Calne, J.K.C. Tsui, and R. de la Fuente-Fernández The long-term response to levodopa in dopa-responsive dystonia Park Relat Disord 8 1 2001 9 1 5
33. C. Buter, and S. Campbell Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy Dev Med Child Neurol 42 2000 634 645
34. D. Dressler, and R. Benecke Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis Eur Neurol 49 2003 34 38
35. D.E. Lumsden, H. Gimeno, K. Tustin, M. Kaminska, and J.P. Lin Interventional studies in childhood dystonia do not address the concerns of children and their carers Eur J Paediatr Neurol 19 3 2015 327 336
36. F.J. Kirkham, P. Haywood, P. Kashyape, J. Borbone, A. Lording, K. Pryde, M. Cox, J. Keslake, M. Smith, L. Cuthbertson, V. Murugan, S. Mackie, N.H. Thomas, A. Whitney, K.M. Forrest, A. Parker, R. Forsyth, and C.M. Kipps Movement disorder emergencies in childhood Eur J Paediatr Neurol 15 5 2011 390 404